Q3 2017 13F Holders as of 30 Sep 2017
-
Type / Class
-
Equity / COM
-
Total 13F shares
-
35,289,564
-
Share change
-
-3,104,044
-
Total reported value
-
$395,009,309
-
Put/Call ratio
-
34%
-
Price per share
-
$11.20
-
Number of holders
-
125
-
Value change
-
-$33,707,622
-
Number of buys
-
58
-
Number of sells
-
63
Institutional Holders of SCICLONE PHARMACEUTICALS INC - COM (SCLN) as of Q3 2017
As of 30 Sep 2017,
SCICLONE PHARMACEUTICALS INC - COM (SCLN) was held by
125 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
35,289,564 shares.
The largest 10 holders included
BlackRock Inc., VANGUARD GROUP INC, DIMENSIONAL FUND ADVISORS LP, GLG Partners LP, STATE STREET CORP, AQR CAPITAL MANAGEMENT LLC, TWO SIGMA INVESTMENTS, LP, Marshall Wace North America L.P., Bank of New York Mellon Corp, and NORTHERN TRUST CORP.
This page lists
125
institutional shareholders reporting positions in this security
for the Q3 2017 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.